{{Rsnum
|rsid=3771570
|Gene=FARP2
|Chromosome=2
|position=241443449
|Orientation=plus
|GMAF=0.09734
|Gene_s=FARP2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 73.5 | 24.8 | 1.8
| HCB | 81.0 | 18.2 | 0.7
| JPT | 87.6 | 9.7 | 2.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 89.5 | 10.5 | 0.0
| CHB | 81.0 | 18.2 | 0.7
| CHD | 75.2 | 22.9 | 1.8
| GIH | 81.2 | 17.8 | 1.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 79.3 | 17.2 | 3.4
| MKK | 98.1 | 1.9 | 0.0
| TSI | 67.6 | 31.4 | 1.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23535732
  |Trait=Prostate cancer
  |Title=Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
  |RiskAllele=A
  |Pval=5E-9
  |OR=1.12
  |ORtxt=[1.08-1.17]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}